Last Posted: Nov 10, 2022
- Circulating proteome of hospitalized patients uncovers six endophenotypes of COVID-19 and points to FGFR and SHC4-signaling in acute respiratory distress syndrome
W Ma et al, MEDRXIV, November 9, 2022
- Multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS
R Batra et al, MEDRXIV, August 13, 2022
- Drivers of Mortality in COVID ARDS Depend on Patient Sub-Type
H Cheyne et al, MEDRXIV, July 6,2022
- Polymorphism in IFNAR contributes to glucocorticoid response and outcome in ARDS and COVID-19
J Jalkanen et al, MEDRXI, March 13, 2022
- Utilizing machine learning to improve clinical trial design for acute respiratory distress syndrome.
Schwager E et al. NPJ digital medicine 2021 4(1) 133
- The Angiotensin Converting Enzyme Deletion/Deletion Genotype Is a Risk Factor for Severe COVID-19: Implication and Utility for Patients Admitted to Emergency Department.
Annunziata Anna et al. Medicina (Kaunas, Lithuania) 2021 57(8)
- Data-driven identification of ageing-related diseases from electronic health records.
Kuan Valerie et al. Scientific reports 2021 Feb 11(1) 2938
- Risk factors analysis of COVID-19 patients with ARDS and prediction based on machine learning.
Xu Wan et al. Scientific reports 2021 11(1) 2933
- Analytics with artificial intelligence to advance the treatment of acute respiratory distress syndrome.
Zhang Zhongheng et al. Journal of evidence-based medicine 2020 Nov
- Severe COVID-19 Infections—Knowledge Gained and Remaining Questions
LDJ Bos et al, JAMA Internal Medicine, September 18, 2020
HLBS-PopOmics is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to Heart and Vascular Diseases(H), Lung Diseases(L), Blood Diseases(B), and Sleep Disorders(S)...more
Mensah GA, Yu W, Barfield WL, Clyne M, Engelgau MM, Khoury MJ. HLBS-PopOmics: an online knowledge base to accelerate dissemination and implementation of research advances in population genomics to reduce the burden of heart, lung, blood, and sleep disorders. Genet Med. 2018 Sep 10. doi: 10.1038/s41436-018-0118-1
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.